Journal of Vaccines & Vaccination

2^nd International Conference on Vaccines and Vaccination

August 20-22, 2012 Hilton Chicago/Northbrook, USA

Scientific Tracks Abstracts

• Changing the cytokine environment: Implications in mycobacterial immunity for adults and newborns

  Cory M. Robinson

  PDF HTML

• Genetic modification of Francisella tularensis LVS for use as a novel live vaccine platform

  Joseph Horzempa

  PDF HTML

• Induction of protective adaptive immunity against attenuated west nile virus

  Tian Wang

  PDF HTML

• Subversion of the innate immune response of the host by gram-negative pathogens

  Kei Amemiya

  PDF HTML

• Vaccine formulation: A balancing act of antigen and adjuvant stabilization

  Maya Salnikova

  PDF HTML

• New mechanism of CD8 T cell differentiation upon combinatorial activation by antigen and cytokine

  Yutaka Tagaya

  PDF HTML

• Dendritic cells molecular signatures as a tool for adjuvants selection

  Maria Foti

  PDF HTML

• The role of B lymphocyte-induced maturation protein-1 (Blimp-1) in the plasma cells

  Kuo-I Lin

  PDF HTML

• Photodynamically inactivated Leishmania as a potential novel carrier for vaccine delivery against infectious and non-infectious diseases

  Kwang Poo Chang, Sujoy Dutta and Bala K. Kolli

  PDF HTML

• Cytokine and T cell responses to seasonal influenza vaccination in adults

  Jay Bream

  PDF HTML

• Persistence of memory B cells by inhibition of caspase-9-dependent and independent cell death

  Jin Wang

  PDF HTML

• TCR signaling pathways regulating CD8+ T cell survival during the expansion phase

  Anne S. De Groot, Timothy J. Messitt, Matthew Ardito, Christine Boyle, Leonard Moise, Lesley Dupuy, Connie Schmaljohn and William Martin

  PDF HTML

• Vaccination with HLA class-I presented viral epitopes

  William Hildebrand

  PDF HTML

• Human ?d T cell responses to infections and cancer: From basic immunology to immunotherapy

  Marc Bonneville

  PDF HTML

• Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: Reversal by adenoviral vaccine

  Jos� Ronnie Vasconcelos

  PDF HTML

• Development of cancer vaccines targeting brachyury, a driver of the epithelial-mesenchymal transition of human carcinomas

  Claudia Palena

  PDF HTML

• Mechanisms of tumor-induced myeloid-derived suppressor cell development

  Scott I. Abrams

  PDF HTML

• Combining targeted therapy with immunotherapy (interferon-a): Rational, efficacy in gastrointestinal stromal tumor model, and implications in other malignancies

  Lei L Chen

  PDF HTML

• Cancer testis antigens: Novel targets for ovarian cancer

  Maurizio Chiriva Internati

  PDF HTML

• Efficient induction of T cell activation by CH401MAP peptide; Her2 (N:163-182) in vitro

  Banri Tsuda

  PDF HTML

• Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice

  D.N. Rao and Riyasat Ali

  PDF HTML

• Analysis and distribution of CD4+ multi-intent epitope candidates against flaviviridae family

  V. Rainone, K. �berla, V. Temchura, D. Trabattoni, A. Clivio, F. Veas, M. Nebuloni and M. Clerici

  PDF HTML

• Immunogenicity of novel dengue virus epitopes identified by immunoinformatics analysis

  Pranita Roy

  PDF HTML

• TNFR Costimulatory ligands as a platform for the development of vaccines

  Haval Shirwan

  PDF HTML

• Use of gut flora as a natural vaccine against autoimmunity

  Joseph Larkin

  PDF HTML

• Rational design of a fully synthetic nanoparticle-based vaccine

  Takashi Kei Kishimoto

  PDF HTML

• Nanoparticles as oral vaccine delivery systems

  Martin J. D?Souza

  PDF HTML

• Diluent pH specification setting for freeze-dried vaccines

  Hong Sun and Jens K?ditz

  PDF HTML

• Development of a therapeutic vaccine to prevent cytomegalovirus infection in transplant recipients

  Michele Gerber

  PDF HTML

• Modulation of peptide conformation in liposomal vaccines for targeting protein misfolding diseases

  P. Reis, D.T. Hickman, M. P. L?pez-Deber, A.Silva, M. Pihlgren, V. Gafner, R. Madani, Annie St-Piere, D. Mlaki Ndao, L. Chan, V. Giriens, N. Chuard, A. Pfeifer and A.Muhs

  PDF HTML

• The impact of HLA Class I on susceptibility to Hodgkin lymphoma is mediated by the magnitude of tumor associated CD8+ T-cell Immunity

  Maher Gandhi

  PDF HTML

• CIMAvaxEGF, an Epidermal Growth Factor (EGF) based cancer vaccine for non small cell lung cancer therapy: Product development and post-marketing experiences

  Gisela Gonzalez Marinello

  PDF HTML

• Nutritive components as safe immune-enhancers in novel and existing vaccine delivery systems

  Michael Vajdy

  PDF HTML

• Opsonokine? Technology: A novel method for enhancing immunity to cell based tumor vaccines

  Eli Young

  PDF HTML

• Molecular adjuvants for therapeutic HIV-1 vaccines

  Andy (Qigui) Yu

  PDF HTML

• Virus-Like Particles (VLP) of animal papillomavirus; PV vaccines and serological studies

  A. Bennett Jenson, Joongho Joh, John P. Sundberg, and Shin-je Ghim

  PDF HTML

• A novel non-integrative one-cycle lentiviral genome derived from a naturally attenuated animal lentivirus as HIV-1 vaccine

  Y. Chebloune, G. Arrode-Bruses, M. Moussa, D. Aldebert, B. Ouzrout, M De Gasperi, A. Malogolovkin, A. Smaoune and Lina Khelifeh

  PDF HTML

• Development of new biotechnology platforms for production of HPV vaccines: Approaches in the context of developing countries

  Filipe Colaco Mariz

  PDF HTML

• Evaluation of anxiolytic effect of the essential oil of Myrtus communis L. in mice

  Pranav Gupta, Rajesh Singh, Edwin W. Ades, David E. Briles, Shailesh Singh and James W. Lillard Jr

  PDF HTML

• Recent advances in vaccination for leishmaniasis using genetically altered live attenuated parasite

  Ranadhir Dey

  PDF HTML

• Developing a multivalent vaccine for lymphatic filariasis ? A neglected tropical disease

  Ramaswamy Kalyanasundaram

  PDF HTML

• A newly developed scrub typhus vaccine candidate: The DNA plasmid carrying the truncated gene of hTRA can protect mice against the homologous challenge of orientia tsutsugamushi

  Wei-Mei Ching

  PDF HTML

• Human hookworm vaccine, a vaccine to prevent intestinal blood loss and transmission caused by the hookworm Necator americanus

  Coreen M. Beaumier, Jeffrey Bethony, Alex Loukas, Marva Loblack, David Diemert, Maria Elena Bottazzi and Peter J. Hotez

  PDF HTML

• A robust and reproducible process for production of a schistosomiasis vaccine

  Elena Curti, Bin Zhan, Portia Gillespie, Clifford Kwityn, Jordan Plieskatt, Wanderson C. Rezende Weiqiang Cheng, Sangeeta B. Joshi, C. Russell Middaugh, Peter J Hotez and Maria E Bottazzi

  PDF HTML

• The road to a sterilizing vaccine for murine schistosomiasis mansoni using larval excretorysecretory molecules and papain or type 2 cytokines as adjuvant

  Rashika El Ridi

  PDF HTML

• Plasmodium vivax tryptophan-rich antigens

  Y.D.Sharma, Md. Zeeshan, Rupesh Tyagi and Hema Bora

  PDF HTML

• Quantity control for the Pfs25-EPA conjugate vaccine adjuvanted with alhydrogel?

  Daming Zhu

  PDF HTML

• Non-replicating adenovirus particle as a rapid-prolonged-broad therapeutic agent as well as a vaccine carrier against viral and bacterial infections

  De-chu C. Tang, Jianfeng Zhang, E. Bart Tarbet, Kent R. Van Kampen, Scott D. Parker, Zhongkai Shi, Tsungwei Feng and Diana L. Noah

  PDF HTML

• Opportunities to increase pertussis and measles vaccine uptake

  Alwyn Rapose

  PDF HTML

• The protective antigens in Neisseria meningitidis group B Native Outer Membrane Vesicle vaccines (NOMV)

  Deborah H. Schmiel

  PDF HTML

• Vaccine platforms to control arenaviral hemorrhagic fevers

  Igor S. Lukashevich

  PDF HTML

• Acetalated dextran microparticles for the enhancement of rapid response vaccine for Bacillus anthracis

  Kristy M. Ainslie Kevin Schully, Sadhana Sharma, Kevin Peine, John Pesce, Margaret Elberson, Eric M. Bachelder and Andrea Keane-Myers

  PDF HTML

• Development of a lipopolysaccharide targeted mimic peptide vaccine against Q fever

  Guoquan Zhang

  PDF HTML

• Oral vaccine against leptospirosis

  Maria Gomes-Solecki

  PDF HTML

• Alternative whooping cough vaccines

  Trilochan Mukkur

  PDF HTML

• A new kind of preventive treatment for children pneumonia but not antibody based concept of vaccine

  Sunil Palchaudhuri, and Anubha Palchaudhuri

  PDF HTML

• Development of a quantitative RT-PCR assay for measurement of infectious potency in an HSV candidate vaccine

  Azizi A, Gisonni-Lex L and Laurent M

  PDF HTML

• Status of hepatitis B vaccine and its prospect

  KyungDong Bae

  PDF HTML

• Critical determination of serum concentration of Th1 major cytokines in mice immunized with rSAG1 and subsequently challenged with Toxoplasma gondii

  Vikrant Sudan1 and A.K. Tewari

  PDF HTML

• Cloning and expression of immunogenic molecules of L. major promastigote by Patient?s immune sera

  Hemanta Koley, Soumik Barman, Dhira Rani Saha and Ranajit Kumar

  PDF HTML

• Filovirus vaccines

  Gerardo Kaplan

  PDF HTML

• Development of Ebola virus glycoprotein Fc fusion proteins as a vaccine candidate

  Krishnamurthy Konduru, Amy Shurtleff, Steven B. Bradfute, Jerome Jacques, Mohanraj Manangeeswaran, Sina Bavari, and Gerardo G. Kaplan

  PDF HTML

• rVSV vectored vaccine to protect against Ebola and Marburg viruses

  John H. Eldridge, Thomas W. Geisbert, Heinz Feldmann, David K. Clarke, Chad E. Mire, Andrea Marzi, Stefan Hamm, Demetrius Matassov, Becky Nowak, Terry Latham, Rong Xu, Ayuko Ota-Setlik and Michael A. Egan

  PDF HTML

• Development of BSL-2 neutralization assays for Ebola virus and Marburg virus based on replication-competent recombinant VSV pseudotypes

  Jerome Jacques, Krishnamurthy Konduru, Maria Elisa Piccone and Gerardo Kaplan

  PDF HTML

• Regulatory considerations related to the development of filovirus vaccines

  Robin Levis

  PDF HTML

• Protective immunity to Ebola and Marburg viral infections using a venezuelan equine encephalitis virus replicon expressing filovirus glycoproteins

  Gene Garrard Olinger

  PDF HTML

• Successful treatment of Ebola virus infected nonhuman primates with monoclonal antibodies

  Kobinger G, Qiu X, Audet J, Alimonti J, Wong G, Pillet S, Cabral T and Corbett C

  PDF HTML

• Baculovirus surface displayed hemagglutinin as a mucosal vaccine vector against H5N1 in mice

  Jimmy Kwang

  PDF HTML

• Vaxjo: A web-based vaccine adjuvant database and analysis system

  Yongqun ?Oliver? He

  PDF HTML

• Vaccine adjuvants: Traditional vs Novel

  Maya Salnikova

  PDF HTML

• Strengthening pipeline development through innovative licensing collaborations

  Gavin Zealey

  PDF HTML

• The extensive socioeconomic benefits of vaccines

  Julia A. Walsh

  PDF HTML

• Leveraging community pharmacies to expand access to vaccinations

  Michael S. Taitel

  PDF HTML

• BARDA�s role in advancing medical countermeasure development

  Gerald R. Kovacs

  PDF HTML

• LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in four unrelated diseases

  Daniel H Zimmerman

  PDF HTML

• Effects of therapeutic cancer vaccine composed with dendritic cell and IL-2 in renal cell carcinoma or breast cancer patients

  Hyunah Lee

  PDF HTML

• Anti-vaccine animus in the 21st century: Historical perspectives

  Donald E. Greydanus and HC (ATHENS)

  PDF HTML

• Recent progress with vaccine strategies to prevent or delay recurrence following adjuvant therapy

  Mark J. Ahn

  PDF HTML

• The use of a novel DNA vaccine as immunotherapy during Leishmaniasis

  Laura Manna

  PDF HTML

• Recombinant DNA techniques, synthetic peptides and bioinformatics identify proteins and peptides of Mycobacterium tuberculosis-specific genomic regions important for development of new vaccines against tuberculosis

  AS Mustafa

  PDF HTML

• Consideration on non-clinical studies required for therapeutic peptide vaccines

  Mineo Matsumoto

  PDF HTML

• Perception of the maguindanaon muslim mothers on immunization

  Jake Darpine B. Banggay

  PDF HTML